In this blog post, you can read more about containing and preventing the spread of contagious respiratory pathogens like the Coronavirus Disease 2019 (SARS-CoV-2).
Sepsis is the number one cause of preventable death in the world. It affects 49 million people worldwide every year, of which 11 million die. In the UK, there are 52,000 deaths annually (more than breast cancer and bowel cancer combined). This means, every four hours, someone in the UK dies of sepsis.1
Although capnography has historically been used mostly by anaesthetists, it is becoming more common in different clinical settings, being used by nurses, paramedics and doctors non-anaesthetists in emergency departments, interventional rooms and recovery departments. In this article we talk about the 3 important aspects you must notice in capnography, to interpret and make clinical decisions.
The level of carbon dioxide that is released at the end of an exhaled breath is called End Tidal CO2 (ETCO2) and it reflects the patient’s ventilatory status.2,3,4 In this article we discuss the key facts in understanding this technology and its implications in clinical practice.
So, you want to learn more about the key differentiators that will help determine which pulse oximetry technology to choose? We have outlined some information about our Nellcor™ pulse oximetry technology to help you compare our brand to others.
Here are some key components of Nellcor™ pulse oximetry technology to consider.
1. Sepsis Research (2020) What is Sepsis. Available at https://www.sepsisresearch.org.uk/statistics/
2. Sullivan (2019) 5 things to know about capnography. EMS1. Available at https://www.ems1.com/ems-products/capnography/articles/5-things-to-know-about-capnography-Hr5ETRdXzCoU3fLH/
3. American Association of Sleep Technologists (2018) Technical Guideline End-Tidal CO2. AAST. Available at https://www.aastweb.org/hubfs/End-Tidal%20CO2%20-%20AAST%20Technical%20Guideline.pdf
4. Richardson (2016) Capnography for Monitoring End-Tidal CO2 in Hospital and Pre-hospital Settings: A Health Technology Assessment. Canadian Agency for Drugs and Technologies in Health. Available at https://www.ncbi.nlm.nih.gov/books/NBK362376/